Information of the FLI on the current BT Situation
Bluetongue (BT) is a seasonal, predominantly acute viral disease of sheep and cattle transmitted by small (1-3 mm) hematophagous midges (genus Culicoides). Goats, camelids and wild ruminants are also susceptible. BT is caused by an Orbivirus (family Reoviridae), of which 24 serotypes have been discovered so far. A possible 25th serotype has been detected in Switzerland in 2008. Bluetongue virus (BTV) does not infect humans. Meat and other products of infected animals can be consumed without risk.
Symptoms of BT include lesions of the nasal and oral mucosal surfaces, fever, apathy, nasal discharge, tissue infarctions, labial and lingual edema with cyanotic discoloration, swollen and encrusted nares, coronitis and lameness.
BT was first discovered in South Africa, where it is endemic. Currently, BTV occurs worldwide. Disease incidence peaks in warm and humid summers. BT is notifiable in the European Union. Following the initial detection of BTV serotype 8 (BTV-8) in the Netherlands on August 17, 2006, the virus was also found in Belgium (August 19) and Germany (North Rhine Westphalia, August 21). In 2007 and 2008 BT continued to spread across Germany. Type-specific vaccination was introduced in 2008, and dramatically reduced BTV-8 incidence. In 2009, BTV-8 genome was detected only in a very small number of cases.
Vaccination of ruminants against BTV-8 is currently the only effective means of protection against clinical disease and animal losses. The commercially available vaccines induce a stable immunity in the ruminant population.
In October 2008, BTV-6 was detected in the Netherlands. This serotype had not previously occurred in Europe. Shortly afterwards, it was also detected in Germany (Lower Saxony). The community reference laboratory in Pirbright (UK) found the virus to be closely related to a South African vaccine strain of BTV-6. The restriction zones that had been set up as a precautionary measure were lifted in early March 2009.
- Primary contact for federal and state authorities regarding BTV detection and control
- Confirmatory tests for BTV antibody and genome (follow-up on inconclusive results from regional laboratories)
- Virus isolation and BTV serotyping by type-specific genome detection and serum neutralization tests
- Reference collection of virus strains, genome and serum samples
- Batch release testing of BTV diagnostic assays (ELISA, RT-qPCR)
- Evaluation, standardization and further development of BTV-specific diagnostic methods
- Training courses for regional laboratory personnel
- Execution of national ring trials
- Participation in EU ring trials, working groups and research projects
- Virus isolation by cell culture inoculation and intravenous injection of embryonated chicken eggs
- Pan-BTV genome detection with diverse RT-qPCR methods
- Type-specific BTV detection by RT-qPCR and sequencing
- Characterization of virus strains by genome sequencing
- Antibody detection by ELISA and serum neutralization tests (European serotypes)
- Council Directive 92/119/EEC introducing general Community measures for the control of certain animal diseases and specific measures relating to swine vesicular disease
- Council Directive 2000/75/EC laying down specific provisions for the control and eradication of bluetongue
- Commission Regulation (EC) No. 1266/2007 on implementing rules for Council Directive 2000/75/EC as regards the control, monitoring, surveillance and restrictions on movements of certain animals of susceptible species in relation to bluetongue
- Verordnung über anzeigepflichtige Tierseuchen
- Current federal and state regulations on bluetongue